Evidence map›Paper›PMID 35437755›Full record

ArticleThe Australasian journal of dermatology2022

Characteristics, treatment and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database.

Jeremy Hay, Jeff Keir, Clara Jimenez Balcells, Nikita Rosendahl, Martelle Coetzer-Botha, Tobias Wilson, Simon Clark, Astrid Baade, Cath Becker, Luke Bookallil and 24 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Australasian journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 6 countries.

Jeremy HayUpper Hutt Skin Clinic, Upper Hutt, Wellington, New Zealand.ORCID https://orcid.org/0000-0003-1202-2891
Jeff KeirGeneral Practice Clinical Unit, Medical School, The University of Queensland, Australia.ORCID https://orcid.org/0000-0002-6814-0486
Clara Jimenez Balcells4D Skin Cancer Clinic, Belmont North, New South Wales, Australia.ORCID https://orcid.org/0000-0003-1996-6940
Nikita RosendahlFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0002-5188-7487
Martelle Coetzer-BothaGeneral Practice Clinical Unit, Medical School, The University of Queensland, Australia.ORCID https://orcid.org/0000-0003-4059-327X
Tobias WilsonSCARD, Brisbane, Queensland, Australia.
Simon ClarkFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0003-2674-4801
Astrid BaadeGladstone GP Superclinic, Gladstone, Queensland, Australia.
Cath BeckerWairarapa Skin Clinic, Masterton, New Zealand.
Luke BookallilThe University of New England, Armidale, New South Wales, Australia.
Chris ClifopoulosGeneral Practice Clinical Unit, Medical School, The University of Queensland, Australia.
Tony DickerGeneral Practice Clinical Unit, Medical School, The University of Queensland, Australia.
Martin Paul DenbySilverdale Medical, Silverdale, Auckland, New Zealand.
Douglas DuthieDarwin Skin Cancer Clinic, Parap, Northwest Territories, Australia.
Charles ElliottSolarderm Skin Cancer Practice, Caboolture, Queensland, Australia.
Paul FishburnGeneral Practice Clinical Unit, Medical School, The University of Queensland, Australia.
Mark FoleyThe Skin Clinic, Marlborough - Blenheim, New Zealand.
Mark FranckMoleSafe Skin Cancer Clinic, Windsor, Victoria, Australia.ORCID https://orcid.org/0000-0001-5630-6066
Irene GiamSkin2 Clinic, Deakin, Australian Capital Territory, Australia.
Patricio GordilloCairns Skin Cancer Clinic, Cairns, Queensland, Australia.
Alister LilleymanNewcastle Skin Check, Charlestown, New South Wales, Australia.
Roger MacauleyBateau Bay Medical Centre, Bateau Bay, New South Wales, Australia.
James MaherSkin Cancer Ballarat, Alfredton, Victoria, Australia.
Ewen McPheeEmerald Medical Group, Emerald, Queensland, Australia.ORCID https://orcid.org/0000-0003-4469-6583
Michael ReidNelson Bay Skin Cancer Clinic, Nelson Bay, New South Wales, Australia.
Bob ShirlawLakeside Medical, Springfield Lakes, Queensland, Australia.
Graeme SiggsRegency Medical Clinic, Sefton Park, South Australia, Australia.ORCID https://orcid.org/0000-0003-0866-5966
Robert SparkToukley Family Practice, Toukley, New South Wales, Australia.
John StretchBond University, Robina, Queensland, Australia.
Keith van Den HeeverCQ Skin Cancer Clinic, Bucasia, Queensland, Australia.
Thinus van RensburgKippax Ochre Medical Centre, Holt, Australian Capital Territory, Australia.
Chris WatsonBrisbane City Doctors, Brisbane, Queensland, Australia.
Harald KittlerVienna Dermatologic Imaging Research Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-0051-8016
Cliff RosendahlGeneral Practice Clinical Unit, Medical School, The University of Queensland, Australia.ORCID https://orcid.org/0000-0001-5182-2969
The University of Queensland · AUCancer Australia · AUSkin and Cancer Foundation · AUBallarat Health Services · AUBond University · AUCairns Hospital · AUCancer Clinic · USCapalaba Medical Centre · AUCharles Sturt University · AUCity Eye Centre · AUEmerald Education Systems · USFonterra (New Zealand) · NZGila Regional Medical Center · USGladstone Institutes · USHanson Institute · AUHutt Hospital · NZKimberley Aboriginal Medical Services · AUMedical Lake School District · USMedical University of Vienna · ATNovita · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveGeneral practitioners manage more melanomas than dermatologists or surgeons in Australia. Previously undescribed, the management and outcomes of melanoma patients treated by multiple Australasian general practitioners are examined.

methodsThe characteristics, management and outcomes of 589 melanoma patients, managed by 27 Australasian general practitioners and documented on the Skin Cancer Audit Research Database (SCARD), were analysed.

resultsMost patients (58.9%) were males with mean age at diagnosis of 62.7 years (range 18-96), and most melanomas were in situ or thin-invasive. Patients aged under 40 years had fewer melanomas, but a higher proportion (the majority) were invasive, compared with older patients (P < 0.0001). Most (55.9%) melanomas were diagnosed following elliptical excision biopsy, the rate of unintended involved margins being eightfold higher for shave biopsies. Wide re-excision was performed by the treating general practitioner for most (74.9%) melanomas, with thick melanomas preferentially referred to surgeons. The average Breslow thickness of invasive melanomas re-excised by general practitioners was 0.67 mm compared with 1.99 mm for those referred to other specialists (P < 0.0001). Of 205 patients with invasive melanoma, 14 progressed to metastatic disease, 50% of these being associated with nodular melanoma. Nine patients progressed to melanoma-specific death. The 5-year survival rate for patients with invasive melanoma was 95.2% (95% CI: 91.2-98.5%).

conclusionsDiagnostic and therapeutic management of a series of melanoma patients by Australasian general practitioners were closely aligned with current guidelines and 5-year survival with respect to invasive melanoma was at least as favourable as national population-based metrics.

Indexed as

General PractitionersMelanomaSkin NeoplasmsAdolescentAdultAgedAged, 80 and overCutaneous Malignant MelanomaFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeYoung Adultgeneral practicegeneral practitionermelanomamelanoma 5-year survivalmelanoma managementmelanoma outcomesprimary careSCARD

Identifiers

PMID35437755
PMCPMC9320831
OpenAlexW4224234848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.